| Literature DB >> 35350661 |
Daniela A Ramirez1, Eduardo J Marchevsky2, Juan M Luco2, Alejandra B Camargo1.
Abstract
CYP2A6 is a human enzyme responsible for the metabolic elimination of nicotine, and it is also involved in the activation of procarcinogenic nitrosamines, especially those present in tobacco smoke. Several investigations have reported that reducing this enzyme activity may contribute to anti-smoking therapy as well as reducing the risk of promutagens in the body. For these reasons, several authors investigate selective inhibitors molecules toward this enzyme. The aim of this study was to evaluate the interactions between a set of organosulfur compounds and the CYP2A6 enzyme by a quantitative structure-activity relationship (QSAR) analysis. The present work provides a better understanding of the mechanisms involved, with the final goal of providing information for the future design of CYP2A6 inhibitors based on dietary compounds. The reported activity data were modeled by means of multiple regression analysis (MLR) and partial least-squares (PLS) techniques. The results indicate that hydrophobic and steric factors govern the union, while electronic factors are strongly involved in the case of monosulfides.Entities:
Keywords: CYP2A6; Inhibitors; Organosulfur compounds; Quantitative structure-activity relationship (QSAR)
Year: 2019 PMID: 35350661 PMCID: PMC8957234 DOI: 10.5599/admet.678
Source DB: PubMed Journal: ADMET DMPK ISSN: 1848-7718
CYP2A6 Inhibitory Activity Data of Organosulfur Compounds
| N° | Name | Chemical structure | Residual Activity % |
|---|---|---|---|
| 1 | Dimethyl sulfide |
| 98.4 |
| 2 | Dimethyl disulfide |
| 94.1 |
| 3 | Diethyl sulfide |
| 89.4 |
| 4 | Diethyl disulfide |
| 79.6 |
| 5 | Di-n-propyl sulfide |
| 83.4 |
| 6 | Di-n-propyl disulfide |
| 39.5 |
| 7 | Di-n-butyl sulfide |
| 82.0 |
| 8 | Di-n-butyl disulfide |
| 43.9 |
| 9 | Di-n-amyl sulfide |
| 88.8 |
| 10 | Di-n-amyl disulfide |
| 66.3 |
| 11 | Diallyl sulfide |
| 91.3 |
| 12 | Diallyl disulfide |
| 46.2 |
| 13 | Allyl methyl sulfide |
| 97.6 |
| 14 | Allyl n-propyl sulfide |
| 94.2 |
| 15 | Allyl phenyl sulfide |
| 32.8 |
| 16 | Diphenyl sulfide |
| 46.1 |
| 17 | Diphenyl disulfide |
| 65.7 |
| 18 | Phenyl ciclopropyl sulfide |
| 42.1 |
| 19 | Difurfuryl disulfide |
| 69.1 |
| 20 | 4,4’-dipyridyl disulfide |
| 97.0 |
| 21 | 4,4’-dipyridyl sulfide |
| 3.22 |
| 22 | 2,2’-dipyridyl disulfide |
| 2.26 |
Molecular Descriptors[a] for the compounds described in Table 1
| N° | RA% | CLOGP | Ehomo | Elumo | μ | LDip | RPCG | RNCG | E1u | E3u | SPAM | ASP |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 98.400 | 0.845 | -8.882 | 0.457 | 1.961 | 0.251 | 0.200 | 0.484 | 0.707 | 0.444 | 0.517 | 0.237 | 0.093 |
| 2 | 94.100 | 0.845 | -9.399 | -1.978 | 2.569 | 0.249 | 0.193 | 0.473 | 0.724 | 0.449 | 0.545 | 0.235 | 0.095 |
| 3 | 89.400 | 1.817 | -8.856 | 0.362 | 1.941 | 0.154 | 0.118 | 0.282 | 0.654 | 0.533 | 0.488 | 0.665 | 0.076 |
| 4 | 79.600 | 1.817 | -9.352 | -1.976 | 2.646 | 0.160 | 0.132 | 0.289 | 0.676 | 0.484 | 0.504 | 0.521 | 0.078 |
| 5 | 83.400 | 2.604 | -8.857 | 0.353 | 1.910 | 0.146 | 0.090 | 0.216 | 0.632 | 0.571 | 0.480 | 0.765 | 0.074 |
| 6 | 39.500 | 2.604 | -9.351 | -1.996 | 2.660 | 0.151 | 0.103 | 0.230 | 0.677 | 0.358 | 0.489 | 0.547 | 0.075 |
| 7 | 82.000 | 3.291 | -8.861 | 0.342 | 1.886 | 0.134 | 0.071 | 0.170 | 0.612 | 0.593 | 0.475 | 0.875 | 0.073 |
| 8 | 43.900 | 3.291 | -9.351 | -1.999 | 2.676 | 0.139 | 0.083 | 0.183 | 0.642 | 0.367 | 0.477 | 0.659 | 0.074 |
| 9 | 88.800 | 3.911 | -8.865 | 0.337 | 1.881 | 0.129 | 0.059 | 0.141 | 0.605 | 0.606 | 0.472 | 0.900 | 0.072 |
| 10 | 66.300 | 3.911 | -9.354 | -2.002 | 2.677 | 0.133 | 0.069 | 0.153 | 0.643 | 0.374 | 0.473 | 0.681 | 0.073 |
| 11 | 91.300 | 2.352 | -8.901 | -0.068 | 2.004 | 0.153 | 0.133 | 0.169 | 0.594 | 0.348 | 0.525 | 0.763 | 0.100 |
| 12 | 46.200 | 2.352 | -9.313 | -2.010 | 2.650 | 0.157 | 0.127 | 0.171 | 0.626 | 0.294 | 0.515 | 0.346 | 0.102 |
| 13 | 97.600 | 1.672 | -8.894 | 0.146 | 1.987 | 0.187 | 0.178 | 0.314 | 0.590 | 0.310 | 0.527 | 0.604 | 0.098 |
| 14 | 94.200 | 2.459 | -8.880 | 0.108 | 1.958 | 0.150 | 0.139 | 0.209 | 0.594 | 0.353 | 0.518 | 0.778 | 0.086 |
| 15 | 32.800 | 3.437 | -8.566 | -0.076 | 1.649 | 0.140 | 0.113 | 0.161 | 0.574 | 0.227 | 0.514 | 0.642 | 0.105 |
| 16 | 46.100 | 4.412 | -8.371 | -0.142 | 1.265 | 0.127 | 0.130 | 0.127 | 0.613 | 0.000 | 0.474 | 0.615 | 0.110 |
| 17 | 65.700 | 4.412 | -8.960 | -2.164 | 2.495 | 0.139 | 0.096 | 0.188 | 0.624 | 0.331 | 0.477 | 0.484 | 0.105 |
| 18 | 42.100 | 3.527 | -8.557 | 0.086 | 1.627 | 0.158 | 0.105 | 0.217 | 0.618 | 0.172 | 0.467 | 0.524 | 0.112 |
| 19 | 69.100 | 1.182 | -9.143 | -2.170 | 2.191 | 0.126 | 0.123 | 0.152 | 0.627 | 0.376 | 0.519 | 0.749 | 0.101 |
| 20 | 97.000 | 1.406 | -9.320 | -2.365 | 5.911 | 0.140 | 0.108 | 0.158 | 0.602 | 0.248 | 0.498 | 0.471 | 0.105 |
| 21 | 3.220 | 1.406 | -9.007 | -0.667 | 0.321 | 0.135 | 0.160 | 0.133 | 0.620 | 0.000 | 0.487 | 0.630 | 0.113 |
| 22 | 2.260 | 1.406 | -9.573 | -2.627 | 0.150 | 0.121 | 0.111 | 0.160 | 0.602 | 0.248 | 0.500 | 0.534 | 0.108 |
a For an explanation of the symbols, refer to the text
Figure 1.Relationship between observed and calculated values for (a) equations (1) and (b) equation (2)
Figure 2.2-D plot of discriminant functions DF1 and DF2.
Figure 3.Relationship between observed and calculated values for equation (4).
Statistical parameters and PLS model
| Comp. | R2X(CUM) | R2Y(CUM) | Q2(CUM) | RMSS | F statistical |
|---|---|---|---|---|---|
| CPLS-1 | 0.400 | 0.587 | 0.418 | 9.1347 | 122.380 |
| CPLS-2 | 0.566 | 0.914 | 0.817 | ||
| (r=0.965) (q=0.904) | |||||
Figure 4.Relationship between observed and calculated values by the PLS-1 model derived.
Figure 5.N-probability plot of residuals from the PLS-1 model.
Figure 6.Bar graph of the standardized coefficients of the PLS-1 model.
Predictions from the derived QSAR model
| Known inhibitors | Activity (observed)[ | Activity (predicted)[ | PModX (PS)[ |
|---|---|---|---|
| Nicotine | 98.1 | 91.614 | 0.03391 |
| Tranylcypromine | 12.9 | 29.952 | 0.31252 |
| Cotinine | 96.2 | 99.324 | 0.00343 |
| SM-12502 | 85.9 | 84.476 | 0.01204 |
Activities expressed as RA% (Source: Fujita and Kamataki, 2001)
Predicted activity values (RA%) using the developed PLS-1 model
Probability of belonging to the descriptor space used in the model. In this case, tranylcypromine and SM-12502 they belong, while nicotine and cotinine are borderline.
Figure 7.Permutation graph of the PLS-1 derived model.